4 ms·
That makes a ton sense, except that one wonders if any manufacturer will ever bother proving efficacy. Worse, they may instead double-down on marketing campaign
by wahern 10y ago
That makes a ton sense, except that one wonders if any manufacturer will ever bother proving efficacy. Worse, they may instead double-down on marketing campaigns. Doctors and other professionals, working scientists or not, are susceptible to marketing like anybody else.
So we'd need to see other mechanisms, regulatory or otherwise[1], that would counter that effect. FDA approval is a powerful motivator for 1) companies to find actually effective therapies and 2) as an extremely efficient signaling mechanism to the market regarding efficacy. But it's sub-optimal for many reasons, including erring too heavily on the side of safety. It's just not obvious what would replace it.
Don't forget, snake oil thrives in the free market.
[1] Medicare reimbursements predicated on FDA efficacy approval? I'm not sure insurance companies can be expected to do the right[2] thing. It might be cheaper to reimburse a snake oil treatment that allows the patient to die than to pay a premium for an effective treatment. And while presumably a good doctor would insist on the effective treatment, at the margins the insurance company could expect to profit from allowing their patients to choose the snake oil.
[2] Where "right" means a course of action that maximizes long-term social wealth (i.e. preferring effective treatment and therefore subsidizing research), rather than simply maximizing the short-term utility of patients and profits (i.e. allowing the patients the salve of snake oil, with reimbursements, in lieu of effective treatment).